Edesa Biotech (EDSA) Institutional Ownership $2.38 -0.02 (-0.83%) As of 02:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Edesa Biotech (NASDAQ:EDSA)CurrentInstitutional OwnershipPercentage5.50%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$5.09MNumber ofInstitutional Sellers(last 12 months)0 Get EDSA Insider Trade Alerts Want to know when executives and insiders are buying or selling Edesa Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EDSA Institutional Buying and Selling by Quarter Edesa Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2025Nantahala Capital Management LLC625,000$1.53M0.1%N/A8.899% 5/15/2025Velan Capital Investment Management LP687,500$1.68M1.7%N/A9.789% 5/14/2025Stonepine Capital Management LLC687,500$1.68M1.6%N/A9.789% 2/17/2025Citadel Advisors LLC40,944$70K0.0%N/A1.180% 2/14/2025Two Sigma Securities LLC15,313$26K0.0%N/A0.441% 8/2/2024CM Management LLC90,000$385K0.3%+45.2%2.795% 11/7/2023CM Management LLC417,602$264K0.3%+11.4%13.874% 8/4/2023CM Management LLC375,000$304K0.3%+15.4%1.821% 5/8/2023CM Management LLC325,000$296K0.4%+3.9%1.620% 2/14/2023Susquehanna International Group LLP15,211$33K0.0%N/A0.079% 2/9/2023CM Management LLC312,773$676K0.8%+25.1%1.616% 2/7/2023Lynwood Capital Management Inc.121,845$264K0.3%N/A0.630% 11/4/2022CM Management LLC250,000$230K0.3%N/A1.617% 8/8/2022 Merit Financial Group LLC20,409$33K0.0%N/A0.132% 5/5/2022National Bank of Canada FI10,000$30K0.0%+1,518.1%0.072% 11/16/2021Verition Fund Management LLC13,502$100K0.0%N/A0.102% 10/28/2021180 Wealth Advisors LLC20,000$156K0.0%+33.3%0.151% 9/17/2021Virtu Financial LLC18,938$100K0.0%+17.4%0.143% 8/13/2021180 Wealth Advisors LLC15,000$70K0.0%N/A0.113% 8/13/2021Geode Capital Management LLC74,032$390K0.0%+153.3%0.558% 8/13/2021Vanguard Group Inc.109,158$576K0.0%+88.9%0.823% 5/19/2021Virtu Financial LLC16,138$87K0.0%N/A0.122% 5/12/2021Northern Trust Corp15,349$83K0.0%N/A0.116% 5/12/2021Geode Capital Management LLC29,229$157K0.0%N/A0.222% (Data available from 1/1/2016 forward) EDSA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EDSA shares? During the previous two years, the following institutional investors and hedge funds held shares of Edesa Biotech shares: Velan Capital Investment Management LP ($1.68M), Stonepine Capital Management LLC ($1.68M), Nantahala Capital Management LLC ($1.53M), CM Management LLC ($385K), and Citadel Advisors LLC ($70K), Two Sigma Securities LLC ($26K).Learn more on Edesa Biotech's institutional investors. What percentage of Edesa Biotech's stock is owned by institutional investors? 5.50% of Edesa Biotech's stock is owned by institutional investors. Learn more on EDSA's institutional investor holdings. Which institutional investors have been buying Edesa Biotech's stock? The following institutional investors have purchased Edesa Biotech's stock in the last 24 months: Stonepine Capital Management LLC ($687.50K), Velan Capital Investment Management LP ($687.50K), Nantahala Capital Management LLC ($625K), CM Management LLC ($120.60K), Citadel Advisors LLC ($40.94K), and Two Sigma Securities LLC ($15.31K). How much institutional buying is happening at Edesa Biotech? Institutional investors have bought a total of 2,084,257 shares in the last 24 months. This purchase volume represents approximately $5.09M in transactions. Related Companies UNCY Institutional Ownership IZTC Institutional Ownership QNTM Institutional Ownership IFRX Institutional Ownership APLT Institutional Ownership ABVC Institutional Ownership ICCC Institutional Ownership CUE Institutional Ownership HOWL Institutional Ownership ADVM Institutional Ownership This page (NASDAQ:EDSA) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edesa Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edesa Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
